sb 203580 has been researched along with baicalein in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (baicalein) | Trials (baicalein) | Recent Studies (post-2010) (baicalein) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 1,322 | 9 | 839 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Lei, X; Li, S; Li, Z; Lv, J; Meng, L; Xue, R; Zhang, Y; Zhang, Z | 1 |
Chen, X; Jiang, X; Sun, X; Wan, X; Xu, X | 1 |
2 other study(ies) available for sb 203580 and baicalein
Article | Year |
---|---|
Baicalein reduces the invasion of glioma cells via reducing the activity of p38 signaling pathway.
Topics: Anisomycin; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Drug Synergism; Flavanones; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microglia; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Protein Kinase Inhibitors; Pyridines; Scutellaria baicalensis; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2014 |
Mitomycin induces alveolar epithelial cell senescence by down-regulating GSK3β signaling.
Topics: A549 Cells; Alkylating Agents; Cellular Senescence; Down-Regulation; Epithelial Cells; Flavanones; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Humans; Imidazoles; Mitomycin; p38 Mitogen-Activated Protein Kinases; Plasminogen Activator Inhibitor 1; Pulmonary Alveoli; Pyridines | 2021 |